Showing results (361-370 of 933) with videos related to

Sort By:
Pageof 94
Leukemia & Lymphoma|January 19, 2010
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remissionHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Haematologica|February 14, 2007
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemiaWanlong Ma, Richard Tseng, Mercedes Gorre, et al.
Human Pathology|January 25, 2026
Acute Leukemia with BCL11B Rearrangements: Genetic Landscape, BCL11B Expression, and Therapeutic ResponseGuilin Tang, Sa A Wang, Wei Ying Jen, et al.
Cancer|July 22, 2026
Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaHagop Kantarjian, Wei-Ying Jen, Eitan Kugler, et al.
Cancer|April 17, 2018
Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromeRita Assi, Hagop M Kantarjian, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaWei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
Research Square|April 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progressionVarsha Gandhi, Shady Tantawy, Burcu Aslan, et al.
Cancer|April 28, 2011
Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinibAlfonso Quintás-Cardama, Hagop Kantarjian, Jianqin Shan, et al.
Cancer|October 26, 2007
Low serum albumin level is associated with cytomegalovirus reactivation in patients with chronic lymphoproliferative diseases treated with alemtuzumab (Campath-1H)-based therapiesGautam Borthakur, E Lin, Stefan Faderl, et al.
Leukemia & Lymphoma|October 30, 2009
p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapyEllen J Schlette, Joan Admirand, William Wierda, et al.
Pageof 94